De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.

[1]  T. Barbui.  The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both? , 2004, Seminars in hematology.

[2]  F. Mandelli,et al.  Long‐term evaluation of 164 patients with essential thrombocythaemia treated with pipobroman: occurrence of leukaemic evolution , 2003, British journal of haematology.

[3]  F. Passamonti,et al.  Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea , 2002, Leukemia.

[4]  V. Diehl,et al.  Follow‐up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patients , 2002, American journal of hematology.

[5]  C. Harrison.  Current trends in essential thrombocythaemia. , 2002, British journal of haematology.

[6]  F. Fabris,et al.  Second malignancies in patients with essential thrombocythaemia. , 2002, British journal of haematology.

[7]  S. Sugai,et al.  Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases , 2002, European journal of haematology.

[8]  A. Tefferi,et al.  Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management. , 2001, Blood reviews.

[9]  T. Barbui,et al.  Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long‐term follow‐up of a randomized clinical trial , 2000, British journal of haematology.

[10]  K. Uozumi,et al.  Trisomy 8 in essential thrombocythemia in leukemic transformation. , 2000, Cancer genetics and cytogenetics.

[11]  B. Ridell,et al.  Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment , 2000, Annals of Hematology.

[12]  T. Barbui,et al.  Treatment of essential thrombocythemia with special emphasis on leukemogenic risk , 1999, Annals of Hematology.

[13]  E. Wattel,et al.  Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. , 1998, Blood.

[14]  K. Ohyashiki,et al.  [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)]. , 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[15]  J. Laszlo,et al.  Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. , 1997, Seminars in hematology.

[16]  K. Toba,et al.  [Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis]. , 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  B. Pedersen.  Survival of patients with t(1;7)(p11;p11). Report of two cases and review of the literature. , 1992, Cancer genetics and cytogenetics.

[18]  E. Feliú,et al.  Life expectancy of patients with chronic nonleukemic myeloproliferative disorders , 1991, Cancer.

[19]  K. Kishi,et al.  Primary Thrombocythemia in Japan: A Survey of 225 Patients. , 1991, Leukemia & lymphoma.

[20]  F. Mitelman,et al.  Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. , 1991, Leukemia.

[21]  D. Horsman,et al.  Acquired Robertsonian translocations in hematologic malignancy. A rare mechanism of clonal evolution. , 1990, Cancer genetics and cytogenetics.

[22]  M. Pinto,et al.  Translocation t(1;7) revisited. Report of three further cases and review. , 1988, Cancer genetics and cytogenetics.

[23]  Groupe Français de Cytogénétique Hématologique.  Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique. , 1988, Cancer genetics and cytogenetics.

[24]  P. Meltzer,et al.  Translocation 1;7 in hematologic disorders: a brief review of 22 cases. , 1985, Cancer genetics and cytogenetics.